These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33942478)

  • 21. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should We Postpone Elective Cardiovascular Procedures and Percutaneous Coronary Interventions During the COVID-19 Pandemic?
    Keskin G; Khalil E; Uysal A
    Heart Surg Forum; 2021 Jan; 24(1):E022-E030. PubMed ID: 33635255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients Who Have Undergone Coronary Artery Bypass Grafting vs Those Who Have Not.
    Azzalini L; Ojeda S; Karatasakis A; Maeremans J; Tanabe M; La Manna A; Dautov R; Ybarra LF; Benincasa S; Bellini B; Candilio L; Demir OM; Hidalgo F; Karacsonyi J; Gravina G; Miccichè E; D'Agosta G; Venuti G; Tamburino C; Pan M; Carlino M; Dens J; Brilakis ES; Colombo A; Rinfret S
    Can J Cardiol; 2018 Mar; 34(3):310-318. PubMed ID: 29395703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Hayano M; Furukawa Y; Nakagawa Y; Tazaki J; Imai M; Yamaji K; Tada T; Natsuaki M; Saijo S; Funakoshi S; Nagao K; Hanazawa K; Ehara N; Kadota K; Iwabuchi M; Shizuta S; Abe M; Sakata R; Okabayashi H; Hanyu M; Yamazaki F; Shimamoto M; Nishiwaki N; Imoto Y; Komiya T; Horie M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Am J Cardiol; 2012 Oct; 110(7):924-32. PubMed ID: 22721575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.
    Tam DY; Dharma C; Rocha R; Farkouh ME; Abdel-Qadir H; Sun LY; Wijeysundera HC; Austin PC; Udell JA; Gaudino M; Fremes SE; Lee DS
    J Am Coll Cardiol; 2020 Sep; 76(10):1153-1164. PubMed ID: 32883408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3).
    Matsumura-Nakano Y; Shiomi H; Morimoto T; Yamaji K; Ehara N; Sakamoto H; Takeji Y; Yoshikawa Y; Yamamoto K; Imada K; Tada T; Taniguchi R; Nishikawa R; Tada T; Uegaito T; Ogawa T; Yamada M; Takeda T; Eizawa H; Tamura N; Tambara K; Suwa S; Shirotani M; Tamura T; Inoko M; Nishizawa J; Natsuaki M; Sakai H; Yamamoto T; Kanemitsu N; Ohno N; Ishii K; Marui A; Tsuneyoshi H; Terai Y; Nakayama S; Yamazaki K; Takahashi M; Tamura T; Esaki J; Miki S; Onodera T; Mabuchi H; Furukawa Y; Tanaka M; Komiya T; Soga Y; Hanyu M; Ando K; Kadota K; Minatoya K; Nakagawa Y; Kimura T;
    Am J Cardiol; 2021 Apr; 145():25-36. PubMed ID: 33454340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior Percutaneous Coronary Intervention and Mortality in Patients Undergoing Surgical Myocardial Revascularization: Results From the E-CABG (European Multicenter Study on Coronary Artery Bypass Grafting) With a Systematic Review and Meta-Analysis.
    Mariscalco G; Rosato S; Serraino GF; Maselli D; Dalén M; Airaksinen JKE; Reichart D; Zanobini M; Onorati F; De Feo M; Gherli R; Santarpino G; Rubino AS; Gatti G; Nicolini F; Santini F; Perrotti A; Bruno VD; Ruggieri VG; Biancari F
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005650. PubMed ID: 29440275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between coronary artery bypass grafting surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease.
    Qin Q; Qian J; Wu X; Fan B; Ge L; Ge J
    Clin Cardiol; 2013 Jan; 36(1):54-60. PubMed ID: 23108944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry.
    Sen H; Lam MK; Tandjung K; Löwik MM; van Houwelingen KG; Stoel MG; Louwerenburg HW; de Man FH; Linssen GC; Grandjean JG; Doggen CJ; von Birgelen C
    Int J Cardiol; 2014 Oct; 176(3):885-90. PubMed ID: 25168098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing clinical outcomes in patients with diabetes undergoing coronary artery bypass graft and percutaneous coronary intervention in real world practice in Iranian population.
    Arabi A; Naghshtabrizi B; Baradaran HR; Moradi Y; Asadi-Lari M; Mehrakizadeh A
    BMC Cardiovasc Disord; 2022 Mar; 22(1):75. PubMed ID: 35240990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
    Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
    J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.
    Kawashima H; Serruys PW; Hara H; Ono M; Gao C; Wang R; Garg S; Sharif F; de Winter RJ; Mack MJ; Holmes DR; Morice MC; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Onuma Y;
    JACC Cardiovasc Interv; 2022 Jan; 15(2):193-204. PubMed ID: 34973904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus.
    Li Y; Dong R; Hua K; Liu TS; Zhou SY; Zhou N; Zhang HJ
    Chin Med J (Engl); 2017 Dec; 130(24):2906-2915. PubMed ID: 29237922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.